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For patients with acute myocardial infarction who undergo pri-
mary percutaneous transluminal coronary angioplasty (PTCA), it
is important to promptly identify those in whom a significant
delayed improvement of global left ventricular function is to be
expected as a result of successful treatment. Methods: In 51
patients with acute myocardial infarction who underwent pri-
mary PTCA with a good angiographic result, the late outcome of
the left ventricular ejection fraction (LVEF) was established after
a 6-mo follow-up. In the early phase after infarction (within 1
wk of infarction), the contractile reserve of the infarct zone was
evaluated using dobutamine echocardiography and compared
with the assessment of infarct size, infarct severity, and mean
tracer activity of the infarct zone obtained using resting 99mTc-
sestamibi SPECT. Receiver-operating-curve (ROC) analysis
was used to define the reliability of the various parameters for
identifying the patients with a follow-up LVEF increase of 5
LVEF units. Results: Of the 48 patients without restenosis at
follow-up, 34 showed significant LVEF improvement. The eval-
uation of the contractile reserve of the infarct zone achieved an
ROC curve area of 0.75  0.07 with 74% sensitivity, 71%
specificity, and 73% overall accuracy. Of the 99mTc-sestamibi
SPECT parameters, the extent of the infarct had no diagnostic
value according to ROC analysis. The mean activity of the
infarct zone had an ROC curve area of 0.64  0.09 with 82%
sensitivity, 50% specificity, and 73% overall accuracy. The
infarct severity had an ROC area of 0.76  0.08 (not significant
vs. mean activity and vs. contractile reserve) with 77% sensi-
tivity, 71% specificity, and 75% overall accuracy. Conclusion:
Evaluation of the contractile reserve of the infarct zone using
dobutamine echocardiography and assessment of the tracer
activity of the infarct zone or infarct severity using 99mTc-sesta-
mibi SPECT in the early phase after infarction are able to identify
the patients in whom successful primary PTCA will be followed
by significant late LVEF improvement.
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The purpose of reperfusion therapy in patients with acute
myocardial infarction is to achieve significant myocardial
salvage and to limit the extent of irreversible tissue damage.
Salvaged myocardium is defined precisely as the difference
between the initial area at risk and the final infarct size.
Perfusion SPECT with 99mTc-sestamibi before and after
treatment has been shown to be highly accurate for this
evaluation (1–4). Unfortunately, although the acquisition of
SPECT after treatment (usually at the time of the patient’s
discharge from the coronary care unit or from the hospital)
is almost always feasible, performance of a study before
reperfusion is often difficult because of technical and logis-
tic problems (5). Perfusion images after treatment alone
allow an accurate assessment of the infarct size but no direct
visualization of salvaged myocardium (6–10). In clinical
terms, the main features of salvaged myocardium are to be
an area at high ischemic risk (11) and often to be dysfunc-
tional because of postischemic stunning (12). The introduc-
tion of primary percutaneous transluminal coronary angio-
plasty (PTCA) has significantly improved the chance of
restoring a normal coronary blood flow compared with
thrombolysis, with a consequent decrease in the rate of
ischemic events early and late after reperfusion (13). On the
other hand, even a satisfactory angiographic result after
primary PTCA with reestablished vessel patency does not
always imply an effective tissue reperfusion with conse-
Received Mar. 21, 2001; revision accepted Aug. 29, 2001.
For correspondence or reprints contact: Roberto Sciagra`, MD, Nuclear
Medicine Unit, Department of Clinical Physiopathology, University of Flor-
ence, Viale Morgagni 85, 50134 Florence, Italy.
E-mail: r.sciagra@dfc.unifi.it
8 THE JOURNAL OF NUCLEAR MEDICINE • Vol. 43 • No. 1 • January 2002
quent actual myocardial salvage (14). Because the degree of
left ventricular impairment, as expressed by the left ventric-
ular ejection fraction (LVEF), remains a major prognostic
factor even in patients who have undergone primary PTCA,
there is still a need for methods that recognize viability
within dysfunctioning segments and thus predict the final
outcome of left ventricular function after infarction. The
demonstration of contractile reserve within asynergic seg-
ments using dobutamine echocardiography is effective for
the identification of stunned salvaged myocardium on a
regional basis (15–20). Other data also suggest that the
demonstration of tracer uptake over the viability threshold
in 99mTc-sestamibi SPECT after reperfusion predicts revers-
ible regional dysfunction (21). However, in both instances,
scanty data are available on the relationship between re-
gional viability and prediction of functional outcome de-
fined in terms of global LVEF improvement. The aim of this
study was to verify whether the evaluation of the contractile
reserve with dobutamine echocardiography and perfusion
imaging with 99mTc-sestamibi (both performed on the pa-
tient’s discharge from the coronary care unit) can identify
the patients in whom a significant delayed increase in the
LVEF after reperfusion therapy with primary PTCA is to be
expected or to be ruled out and to compare the 2 methods in
the same patient population.
MATERIALS AND METHODS
Patient Population and Study Protocol
The patient population included 51 consecutive patients (43
men; mean age, 59  12 y) with acute myocardial infarction who
were admitted to our coronary care unit within 6 h of the onset of
symptoms (mean time, 138  90 min; range, 30–360 min) and
who were referred to the catheterization laboratory for emergency
primary PTCA. The diagnosis of acute myocardial infarction re-
quired the presence of typical chest pain lasting 30 min together
with a 0.1-mV ST segment elevation in at least 2 contiguous
electrocardiographic leads. Other inclusion criteria were total oc-
clusion of the infarct-related artery; successful primary PTCA
(defined as Thrombolysis in Myocardial Infarction trial flow grade
3 (22) and residual stenosis of 30% of lumen diameter); and
willingness to participate in the study. Patients were excluded in
the case of clinical instability or cardiogenic shock and if the
echocardiographic window was inadequate for satisfactory visual-
ization of the entire left ventricular wall. Of 62 otherwise eligible
patients, 7 subjects (11%) were excluded on the basis of their
clinical status and 4 (7%) were excluded because of poor quality of
the echocardiographic images. The study protocol included the
acquisition of 2-dimensional (2D) echocardiography to evaluate
regional wall motion and global left ventricular function on ad-
mission of the patient. Dobutamine echocardiography was per-
formed at a mean of 3  1.1 d (range, 2–5 d), and resting
99mTc-sestamibi SPECT was performed at a mean of 6.5  1.2 d
(range, 4–9 d) after index infarction. Follow-up 2D echocardiog-
raphy and coronary angiography were repeated 6 mo later. The
ethics committee of our institution approved the study protocol.
Coronary Angiography
All angiograms were analyzed in a random sequence by 2
experienced observers who were unaware of other results. Dis-
crepancies were resolved by consensus. In all patients, the infarct-
related artery was analyzed before and after primary PTCA to
assess residual stenosis. The same views of coronary arteries were
used on follow-up to assess the arterial patency and restenosis rate.
Low-Dose Dobutamine Protocol
Dobutamine (5 g/kg of body weight per minute) was infused
under continuous electrocardiographic and blood pressure moni-
toring. Infusion was continued for 5 min and then increased to 10
g/kg/min for an additional 5 min. The criteria for early interrup-
tion of dobutamine infusion included hypotension, angina, and
significant ventricular arrhythmia.
2D Echocardiography
Patients were studied at rest and under low-dose dobutamine
infusion in the left lateral decubitus using a commercially available
scanner (Aloka SSD 870, 2.5- and 3.5-MHz transducers; Aloka
Co., Tokyo, Japan). All standard views were acquired and re-
corded on videotape for off-line evaluation of regional wall mo-
tion. For calculation of the LVEF, 2D echocardiographic images
were transferred to the hard disk of a TomTec P90 (TomTec
Imaging Systems, Munich, Germany) medical off-line computer
analysis system and digitized. LVEF was calculated under baseline
resting conditions on admission and follow-up examination.
99mTc-Sestamibi SPECT
The tracer dose was 740–925 MBq (20–25 mCi) and was
injected to the resting patient lying supine. Images were collected
60 min later using a single-head, large-field-of-view tomographic
gamma camera equipped with an ultra-high-resolution collimator
and with a 20% window centered on the 140-keV photopeak of
99mTc. Sixty projections of 20 s each were acquired. Image recon-
struction was performed using filtered backprojection. No attenu-
ation or scatter correction was used. The transaxial slices were
realigned along the heart axis. For quantitative evaluation of
SPECT images, the short-axis slices, from the first with apical
activity to the last with activity at the base, were used. Their count
profiles were generated by computer software and plotted onto a
2D volume-weighted polar map.
Data Analysis
For the echocardiographic evaluation, the left ventricular wall
was divided in 16 segments (23), and 2 infarct zones (anterior and
inferior, the latter including also the lateral wall) were defined as
theoretic maximal risk areas (17). Because the apical lateral and
the apical inferior segments can be perfused by anterior (left
anterior descending) and posterior (right coronary or left circum-
flex) arteries, they were considered as overlap segments; thus, each
infarct zone included 9 segments (17). Two experienced observers,
who were unaware of patient data and image sequence, examined
independently the studies and scored the segmental wall motion as
follows: 1  normal, 2  hypokinesis, 3  akinesis, and 4 
dyskinesis (17). In evaluating wall motion abnormalities, attention
was also paid to systolic thickening in the central portion of the
segment. Discrepancies were resolved by consensus. The appro-
priate infarct zone was identified in each patient and its wall
motion score index, which is the sum of the segment scores
divided by 9, was derived for baseline and dobutamine echocar-
diograms. The contractile reserve was defined by the difference
between baseline and the dobutamine wall motion score index
(17). The LVEF was measured with the modified Simpson’s rule
algorithm (24). The mean values of 3 measurements of the tech-
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nically best cardiac cycles were taken from each examination.
Improvement of global LVEF after revascularization was arbi-
trarily defined as an increase of 5 LVEF units in the follow-up
control compared with the baseline value (25).
For SPECT evaluation, the polar map displays were divided into
16 segments, matching with the echocardiographic ones. Using an
automated procedure, segment tracer activity was calculated as the
total of the normalized counts of the pixels included within the
segment divided by the number of pixels. The segment with
maximal activity was then normalized to 100, and the activity of
the other segments was expressed as a percentage of the peak
activity segment (26). Segmental 99mTc-sestamibi activity was
classified as mild to moderately abnormal if it was 75% and
50% of the peak value and as severely abnormal if it was 50%
of the peak value. The same infarct zones defined for echocardi-
ography were considered. For each infarct zone, the following
parameters were determined: mean 99mTc-sestamibi activity value,
calculated as the sum of the activity in the related segments
divided by 9; extent of infarct, expressed as the total number of
segments with abnormal uptake; and severity index of the infarct,
calculated as the number of segments with severely decreased
99mTc-sestamibi uptake divided by the total number of segments
with abnormal uptake.
Statistical Analysis
Data are expressed as the mean  SD. Comparisons of contin-
uous variables within and between groups were performed using
the Student t test for paired or unpaired samples, with the Bonfer-
roni correction for repeated measures, as appropriate. The diag-
nostic power of the echocardiographic and scintigraphic variables
for predicting a significant improvement in LVEF was assessed
using receiver-operating-characteristic (ROC) curves. Each area
was expressed as SE and compared using Wilcoxon statistics.
P  0.05 was considered statistically significant.
RESULTS
Patient Characteristics
The location of the infarct, according to the electrocar-
diographic changes and the wall motion abnormalities, in-
volved the anterior infarct zone in 26 patients and the
inferior infarct zone in 25 patients. The infarct-related artery
was the left anterior descending artery in 26 patients, the left
circumflex artery in 2 patients, and the right coronary artery
in 23 patients. Thirty-three patients were affected by single-
vessel coronary artery disease, 12 by 2-vessel disease, and 6
by 3-vessel disease. The LVEF on admission was 44% 
9%. Primary PTCA was successful in all patients and was
performed without complications. Stenting of the dilated
infarct-related artery was performed in 26 patients. The
peak creatine phosphokinase release reached 2,922  2,453
IU/L.
Follow-Up
On follow-up at 6 mo, 3 patients had severe (70%)
restenosis of the infarct-related vessel and, therefore, were
excluded from analysis. In the remaining 48 patients, the
baseline LVEF (43.4%  8.6%) increased to 51.9% 
11.4% at 6 mo (P  0.00001). However, only 34 patients
showed a significant (5 LVEF units) improvement. The
6-mo LVEF of these patients was 55.6%  8.9%, signifi-
cantly higher than on admission (43.3%  8.6%; P 
0.00001). The LVEF was unchanged in 14 patients
(42.8%  12% at 6 mo vs. 43.6%9.2% on admission; not
significant). Table 1 compares the main features of the 2
groups.
Dobutamine Echocardiography
All 48 patients still had an abnormal infarct zone wall
motion at the time of dobutamine echocardiography. The
mean baseline wall motion score index was 2.1  0.47
(range, 1.22–2.77). The dobutamine infusion protocol was
concluded in all patients without complications. According
to the comparison between baseline and dobutamine wall
motion score index, 19 patients showed no contractile re-
serve, and the remaining 29 had a decrease in wall motion
score index ranging from 0.11 to 0.89 (mean, 0.35  0.19).
A significant difference in the dobutamine-induced change
in wall motion score index was registered between the 34
patients with significant LVEF improvement (0.26  0.23)
and the 14 without significant improvement (0.08  0.15;
P  0.05). The area under the ROC curve for contractile
reserve was 0.75  0.07. The best threshold of the decrease
in wall motion score index to detect patients with significant
global LVEF improvement was set at 0.11. With this
cutoff, sensitivity was 74% and specificity was 71%, with
86% positive predictive value, 53% negative predictive
value, and 73% overall accuracy.
99mTc-Sestamibi SPECT
Of the 432 segments included within the infarct zones of
the 48 patients in whom functional follow-up analysis was
TABLE 1
Comparison of Clinical, Angiographic, Echocardiographic,
and SPECT Variables in Patients With Versus Those
Without Significant LVEF Improvement on Follow-Up
Variable
LVEF increase
5% 5% P
Age (y) 58.7  13.4 58  10 NS
No. of stenotic coronary
vessels 1.6  0.7 1.3  0.6 NS
Time to reperfusion (min) 141  91 134  92 NS
CK peak (IU/L) 2,533  2,206 3,373  2,560 NS
Admission LVEF (%) 43.3  8.6 43.6  9.1 NS
Baseline wall motion score
index 2.1  0.5 2.2  0.5 NS
Dobutamine wall motion
score index 1.8  0.5 2.1  0.5 NS
Delta wall motion score
index 0.26  0.23 0.08  0.15 0.05
Infarct extent 5.9  2.5 6.4  2.3 NS
Mean sestamibi activity 67.8  12 61.5  13.5 NS
Infarct severity index 0.19  0.23 0.45  0.26 0.02
NS  not significant; CK  creatine phosphokinase; Delta  rest
to dobutamine.
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completed, 290 showed an abnormal 99mTc-sestamibi up-
take, with a mean of 6  2.4 segments per patient (range,
0–9). The mean activity of the infarct zone was 65.9% 
12.7% (range, 39.8%–86.2%). A severely depressed 99mTc-
sestamibi uptake was registered in 93 segments, with a
mean of 1.9  2.2 (range, 0–7) segments per patient. The
severity index of the infarct ranged from 0 to 0.78, with a
mean of 0.27  0.26. Table 1 compares the 99mTc-sestamibi
SPECT results in patients with LVEF improvement versus
those without LVEF improvement. The single variable that
was significantly different between the 2 groups was the
severity index of the infarct.
Figure 1 and Table 2 compare the diagnostic reliability of
the various SPECT variables for recognizing patients with
significant LVEF improvement on follow-up. The area un-
der the ROC curve for the extent of infarct was just above
the limit of no discrimination. The area under the ROC
curve for the mean 99mTc-sestamibi activity of the infarct
zone was significantly larger (P  0.05). With a cutoff of
60% of peak activity, sensitivity was 82%, specificity was
50%, and overall accuracy was 73%. The best ROC curve
was obtained using the severity index of the infarct, with an
area significantly larger than that of the extent of the infarct
(P  0.01) but not larger than that of 99mTc-sestamibi
activity (P  0.09). Using a cutoff of 0.33, 77% sensi-
tivity, 71% specificity, and 75% overall accuracy were
achieved. No significant difference in the area under the
ROC curve was registered between the contractile reserve
using dobutamine echocardiography and either the mean
99mTc-sestamibi activity or the mean severity index of the
infarct in perfusion SPECT. Accordingly, the diagnostic
reliability (sensitivity, specificity, predictive values, and
overall accuracy) of the 3 parameters (contractile reserve,
infarct severity, and mean 99mTc-sestamibi activity) was
closely comparable.
DISCUSSION
The main finding of this study is that 99mTc-sestamibi
perfusion SPECT and dobutamine echocardiography are
able to recognize with satisfactory accuracy the patients in
whom the LVEF will spontaneously improve after success-
ful primary PTCA for acute myocardial infarction. There-
fore, independent of the extent of the initial area at risk and
of the final infarct size, the presence of myocardial stunning
caused by the presence of salvaged myocardium as a result
of effective reperfusion can be inferred.
Reperfusion therapy is nowadays the standard treatment
for patients with acute myocardial infarction who are ad-
mitted to the hospital within a reasonable time interval after
the onset of symptoms (27). Thrombolytic therapy and
primary PTCA have been shown to be effective in limiting
the extent of myocardial necrosis, thereby improving symp-
toms and decreasing the rate of complications and the early
and late mortality (13,28). However, the effectiveness of
therapy in the individual patient is influenced by several
factors and is more difficult to establish. This is especially
true for systemic thrombolysis, because even the recanali-
zation of the infarct-related vessel remains uncertain. How-
ever, in the case of direct PTCA, a satisfactory angiographic
result with reestablished vessel patency does not always
imply an effective tissue reperfusion with consequent actual
myocardial salvage (14). Therefore, imaging techniques
able to identify the risk area involved by the myocardial
infarction, the final damage after reperfusion therapy, and,
by difference, the extent of myocardial salvage would be
desirable. Myocardial perfusion SPECT with 99mTc-sesta-
mibi before and after treatment fulfills all of the require-
ments of an ideal imaging modality for this particular issue
(1–4), but various practical problems limit the wide appli-
cation of imaging before reperfusion to all patients with
acute myocardial infarction (5). Myocardial contrast echo-
FIGURE 1. ROC curves constructed using contractile reserve
assessed by dobutamine echocardiography and 3 different pa-
rameters derived from sestamibi SPECT for detection of signif-
icant late LVEF improvement after primary PTCA.
TABLE 2
Diagnostic Reliability of Various Sestamibi SPECT
Variables for Detecting Patients with Significant
LVEF Improvement on Follow-Up
Variable
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
Infarct extent 62 50 75 35 58
Mean sestamibi activity 82 50 80 53 73
Infarct severity index 77 71 87 59 75
PPV  positive predictive value; NPV  negative predictive
value.
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cardiography performed immediately before reperfusion
and repeated thereafter has been used, but published data
indicate that this method has a low specificity (19,21,29).
Thus, major efforts have been undertaken to identify imag-
ing modalities that are able to give at least part of the needed
information with a single examination performed after the
reperfusion therapy has been completed but before the pa-
tient’s discharge.
Dobutamine echocardiography is highly reliable in iden-
tifying the asynergic segments that will show spontaneous
function recovery after acute myocardial infarction (15–20).
These segments, which include viable stunned myocardium,
can be differentiated because of the presence of contractile
reserve during inotropic stimulation from the irreversibly
damaged regions. So far, limited data on the relationship
between the extent of contractile reserve and the presence of
significant late increase of global LVEF have been available
(20). According to our results, the detection of any contrac-
tile reserve in the infarct zone is able to recognize with good
accuracy the patients in whom the LVEF will increase on
late follow-up after myocardial infarction. Even a minimal
wall motion improvement during dobutamine infusion ap-
pears predictive of late significant improvement of the
LVEF, so that a lower threshold of the wall motion score
change of the infarct zone was selected compared with that
in previous reports (17,20). On the other hand, a remarkable
proportion of patients without a contractile reserve showed
a significant LVEF improvement on follow-up, and thus the
low negative predictive value appears to be the most im-
portant limitation of dobutamine echocardiography in our
series.
The assessment of infarct size in a 99mTc-sestamibi
SPECT study acquired at the time of hospital discharge is a
very useful parameter for stratifying patients’ risk and a
possible endpoint for establishing the effectiveness of dif-
ferent therapeutic regimens (5,9). A close relationship exists
between the infarct size assessed with 99mTc-sestamibi
SPECT performed at the time of hospital discharge and the
LVEF late after acute myocardial infarction (6,7). In addi-
tion, this parameter has an important prognostic implication
(8). However, myocardial salvage may be present indepen-
dently from the degree of final impairment of left ventric-
ular function. A discrepancy between infarct size and the
LVEF at hospital discharge has been shown to be an indirect
sign of the presence of myocardial stunning, but the diag-
nostic reliability of this approach is not defined (10). Other
data suggest that the simple recognition of 99mTc-sestamibi
activity over the viability threshold in asynergic segments
early after myocardial infarction is predictive of spontane-
ous recovery at 1 mo (21). Recently, Hamby¨e et al. (30)
reported that a specific pattern of decreased 99mTc-sestamibi
uptake and even more depressed -methyl-p-iodophenyl-
pentadecanoic acid activity is predictive of significant re-
covery of the LVEF after revascularization in infarct pa-
tients. Starting with these premises, we attempted to
establish whether any parameters that can be obtained from
99mTc-sestamibi SPECT after reperfusion are predictive of
spontaneous LVEF increase. Because the initial extent of
the area at risk was unknown, we chose to evaluate the
SPECT data on the basis of standard infarct zones, as in
previous studies using dobutamine echocardiography
(17,19,20). Among the examined parameters, we considered
the extent of infarct, the mean tracer activity of the infarct
zone, and, finally, the severity of the residual damage,
expressed by the incidence of segments with severely re-
duced activity over the segments with abnormal uptake. On
the basis of our results, the first parameter did not differen-
tiate the patients with late functional improvement from the
others. This was shown by the lack of a significant differ-
ence in the mean extent of infarct between the 2 groups of
patients. In addition, the results of ROC analysis showed an
area under the curve just above the limit of diagnostic
uncertainty. Conversely, the areas under the ROC curves
constructed using the mean 99mTc-sestamibi activity and,
above all, the severity index were significantly larger and
were not significantly different than that of the contractile
reserve assessed by dobutamine echocardiography. Accord-
ingly, the sensitivity, specificity, and overall accuracy of
those parameters were very close to the related values
achieved using dobutamine echocardiography. Interest-
ingly, considering either the mean activity of the infarct
zone or the severity of the infarct, instead of the extent of
the infarct, the reliability of 99mTc-sestamibi SPECT alone
approached the diagnostic reliability of the combined eval-
uation of perfusion and metabolism proposed by Hamby¨e et
al. (30), with the advantage of a simpler and widely avail-
able imaging protocol. With regard to the possible physio-
pathologic explanation of our results, it is reasonable that
patients in whom the residual damage after revasculariza-
tion includes a prevalence of severely necrotic segments
(with reduced mean tracer activity) do not to show a sig-
nificant recovery on follow-up, because the proportion of
residual viable stunned myocardium within the infarct area
is probably limited and irreversible myocardial damage is
already established.
The limitations of this study must be considered. The
choice of analyzing the data on the basis of theoretic max-
imal risk areas (standard infarct zones) was justified by the
lack of an objective criterion to define the true initial risk
area. However, this is an important limitation because the
possibility of infarcts extending over boundaries of the
infarct zones cannot be ruled out. In our series we did not
observe asynergic segments outside the infarct zone in any
patient, but this remains theoretically possible. The use of a
low-dose dobutamine protocol precluded the possibility of
examining the presence of ischemia or biphasic responses.
Similarly, the execution of stress imaging could have in-
creased the value of perfusion scintigraphy. However, the
study protocol required as inclusion criterion the optimal
result of primary PTCA and, hence, a low likelihood of
inducible ischemia early after the procedure had to be
expected. Although all patients were in apparently stable
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clinical conditions, the time interval between the execu-
tion of dobutamine echocardiography and 99mTc-sestamibi
SPECT is another potential limitation for a comparison of
the 2 methods. With regard to the SPECT parameters that
we evaluated, none of them is optimal and devoid of po-
tential criticisms. The mean activity within the infarct zone
attempts to approximate the threshold method that is widely
adopted for the evaluation of myocardial viability in pa-
tients with chronic coronary artery disease and left ventric-
ular dysfunction (26,31). It is noteworthy that the best
threshold identified for this parameter by ROC analysis was
set at 60% of peak activity, in agreement with previous
studies (21,26,31). The estimate of the extent of the infarct
in terms of the number of infarct zone segments with
abnormal tracer uptake is very rough. Also, our proposal of
a severity index could be criticized for the same reason.
Most previous studies of infarct size used a fixed activity
threshold over the entire left ventricular wall and did not
consider a segment model (5–10), so this approach was
difficult to reconcile with the concept of infarct zone and
to compare with echocardiography. Furthermore, severity
was not considered. The assessment of the extent and
severity of the infarct using the comparison with a nor-
malcy database could be a possible alternative (32), but,
again, it would be difficult to adapt the data to the use of
a standard infarct zone.
CONCLUSION
The results of this study confirm the value of dobutamine
echocardiography for the detection of stunned salvaged
myocardium early after acute myocardial infarction and
define its diagnostic reliability for the prediction of LVEF
outcome. In addition, the perfusion pattern evaluated by
means of a single 99mTc-sestamibi SPECT study after reper-
fusion therapy is able to identify those patients in whom
myocardial salvage will lead to a delayed increase in the
LVEF. In particular, the presence of functional recovery is
related to the infarct severity and mean tracer uptake. These
parameters, together with the infarct size, could be useful in
assessing the effectiveness of acute reperfusion therapy in
patients with acute myocardial infarction and in guiding the
subsequent management of the patient.
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